Were you looking for information about Ilaris? Ilaro is a common misspelling of Ilaris.
Ilaris® (canakinumab) is prescribed to treat a group of symptoms called cryopyrin-associated periodic syndromes (CAPS), a group of rare genetic conditions that cause inflammation throughout the body. It is also approved for systemic juvenile idiopathic arthritis (SJIA).
This medication comes as an injection that is given just under the skin (subcutaneously) once every eight weeks for CAPS or every four weeks for SJIA. Your specific dosage will depend on your age, weight, which condition is being treated, and how you respond to the medication.
Although many people may not have any problems with this medicine, some people who use Ilaris will experience side effects, such as headaches, nausea, and common cold symptoms. Fortunately, such reactions are often mild and easily treated.
(For more information on this medicine, click Ilaris. This full-length article offers a complete overview of this product, including how it works, safety warnings and precautions, and general dosing guidelines. You can also click any of the links in the box to the right for specific information.)